No one could imagine Northwest (OTC: NWBO) shares were more microscopical than the current penny value. Five years ago the stock was trading at $0.18 per share. However, on May 6 early NWBO holders could say they got more than 600% ROI since 2017.
Because of recent developments in the UK facility, NWBO could remain above $0.50. For a while, it is not enjoying profits but still generating a decent revenue of $403K (as of March 2022).
Looking at Northwest’s future plans for manufacturing DCVax an ordinary investor may consider spending several thousand this year. This move is of course motivated by the expected revenue generated by the recent candidate that can combat cancer.